[Players from the program "Investments for the Future": MAbImprove MabEx]

Med Sci (Paris). 2019 Dec;35(12):1204-1205. doi: 10.1051/medsci/2019249. Epub 2020 Jan 6.

[Article in French]

Authors

Mélusine Larivière¹, André Pèlegrin², Pierre Martineau², Hervé Watier³

Affiliations

¹ EA7501, Université de Tours, Tours, France.
² Institut régional du Cancer de Montpellier (IRCM), Inserm U1194, Université de Montpellier, Montpellier, France.
³ EA7501, Université de Tours, Tours, France - CHU de Tours, Tours, France.

PMID: 31903941
DOI: 10.1051/medsci/2019249

No abstract available

Publication types

Historical Article
Review

MeSH terms

Antibodies, Monoclonal / biosynthesis
Antibodies, Monoclonal / economics
Antibodies, Monoclonal / isolation & purification*
Antibodies, Monoclonal / therapeutic use
Biomedical Research / economics*
Biomedical Research / organization & administration*
Biomedical Research / trends
France
History, 21st Century
Humans
Investments / history
Investments / organization & administration*
Investments / trends*
Laboratories / economics
Laboratories / organization & administration
Laboratories / standards
Laboratories / trends
Molecular Targeted Therapy* / economics
Molecular Targeted Therapy* / trends

Substances

Antibodies, Monoclonal